Cardiac Molecular Imaging

Cardiac molecular imaging in cancer research involves the utilization of advanced imaging techniques to probe molecular processes within the heart affected by cancer or cancer treatments. By employing molecular imaging modalities such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT), researchers can visualize specific molecular targets or pathways implicated in cardiac complications associated with cancer therapy. This approach enables early detection of cardiac toxicity, monitoring of treatment response, and optimization of therapeutic strategies to minimize adverse effects on the heart. Additionally, cardiac molecular imaging facilitates a deeper understanding of the underlying mechanisms of cardiotoxicity, paving the way for the development of targeted interventions to preserve cardiac function in cancer patients.